Related Experiment Video
Updated: Jun 17, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
Factors affecting the accuracy of bisphenol a and bisphenol a-monoglucuronide estimates in Mammalian tissues and
J Waechter1, C Thornton, D Markham
1Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, MI, USA.
Abstract:
ABSTRACT Bisphenol A (BPA) (CAS Number 80-05-7; EINECS Number 201-245-8) is used in the production of plastics having food contact applications. Some biomonitoring studies have reported free BPA in blood or urine of humans. Since complete first-pass metabolism of orally administered BPA to BPA-monoglucuronide (BPA-G) occurs in humans, the presence of free BPA in human specimens raises questions as to the origin and/or possible sources of the free BPA. We hypothesized that BPA-G instability during specimen collection and analysis contributes to the presence of free BPA in the biological samples. Investigation of the in vitro hydrolysis of BPA-G in blood plasma, tissue homogenates, and diluted urine from laboratory rats and in aqueous/organic solutions commonly used for extraction in BPA analyses lent support to the hypothesis of BPA-G instability as a possible source of free BPA determinations in the biological specimens. Hydrolysis of BPA-G occurred at neutral pH and room temperature in diluted urine and in rat placental or fetal tissue homogenates at room temperature. Hydrolysis of BPA-G in aqueous/organic solutions began within minutes at pH 2 and 80 degrees C. BPA-G was degraded to an unidentified compound in a urine/water mixture or when stored in a 25/75 mixture of urine/acetonitrile at pH 9 at either 22 or 80 degrees C. Based upon these experiments, it was concluded that methods demonstrating BPA-G stability or accounting for its instability during analysis are warranted in studies designed to measure free BPA in biological specimens.
Related Concept Videos
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Measurement of Bioavailability: Pharmacokinetic Methods
Drug Concentrations: Measurements
Plasma —...
